How Long Should I Stay on GLP-1? (October 2026)

01 · The core answer

How long should you stay on a GLP-1?

You stay on a GLP-1 for as long as the benefit outweighs the downsides, and that judgement is reviewed rather than set in advance. Mounjaro (tirzepatide) is licensed for weight management in adults, used alongside a reduced-calorie diet and increased physical activity.¹ The licence describes how to start and step up the dose. It does not give every patient the same finish line.

That is why you will see such different answers online. Someone who has reached a healthy weight and wants to stop has a different question from someone with a weight-related health condition who is still benefiting. Our guides on how long to take GLP-1 treatment and how long you might be on GLP-1 cover the same ground from other angles.

Everyone starts on 2.5mg once a week. After at least four weeks the dose moves to 5mg, and can then step up in 2.5mg steps at minimum four-week intervals, to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

02 · What you are really deciding

The two decisions you are actually facing

Most readers are facing one of two decisions: whether the treatment is working well enough to carry on, or whether they are ready to stop. Both are better made with data than with a calendar.

If you are still titrating, the question is mainly about dose. Higher is not automatically better, and many people settle at a maintenance dose of 5mg, 10mg or 15mg, with the prescriber guiding the pace.¹ If you have been on a steady dose for a while, the question becomes whether the results and your health markers justify continuing.

If you are comparing options before you begin, our weight loss clinic page explains how treatment and reviews fit together.

03 · The review checkpoint

The 6-month response review and what it means

The one formal response checkpoint is built around how much weight you have lost on your highest tolerated dose. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹

Note what this is and is not. It is a conversation, not an automatic cut-off, and it applies to the highest dose you can tolerate, not to the starting dose. Someone still on the lower rungs of the ladder has not yet reached the point where this check is meaningful.

In practice, that means the early months are about finding your dose, and the question of how long to stay on treatment only becomes sharper afterwards. If you are on a lower dose, our guides on how long to stay on 5mg Mounjaro and how long you stay on the 2.5mg starter dose explain what is normal at each step.

Our prescribing team offers ongoing monthly reviews, dose titration and follow-up assessments, and repeat orders re-check suitability rather than shipping automatically. That structure exists so the decision to continue is made deliberately each time, not by default.

04 · Pace and expectations

Realistic pace: think in months, not days

Weight loss on Mounjaro is gradual by design, so judging whether to continue after only a short time usually misleads. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.¹ Trials measured results at 72 weeks, so the headline figures describe a long course of treatment, not a quick fix.

The best-known example is SURMOUNT-1, a trial of 2,539 adults. People taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

For a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. That is an average from a long trial, not a prediction for you, and it says nothing about how quickly any individual reaches it.

Earlier on, expectations should be lower. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. A sensible expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation. Slower early progress does not predict failure, because the dose you respond to may still be ahead of you.²

This matters for the stay-or-stop question. Many people consider stopping at exactly the point when the dose is only just becoming effective. Our guide on how long you stay on Mounjaro in week one covers what the earliest stage feels like.

05 · Plateaus are not an exit signal

Plateaus: a reason to review, not to quit

A stall on the scales is common and is not, by itself, a reason to stop treatment. Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight.¹

Within the licence, the sensible responses are to:

• review food intake honestly, because portions drift back up;
• protect protein and activity;
• check the basics, such as sleep and alcohol;
• discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.

A plateau is not a reason to double doses or add unlicensed products.¹ Judge progress by trend, not individual weigh-ins, since early loss includes water weight and day-to-day readings move around.

If a plateau persists at your top tolerated dose, that is exactly the situation the response review is designed for. Bring your recent trend, not a single number, to the conversation.

06 · Benefits beyond weight

Benefits beyond the scales

Part of the case for staying on treatment is health markers, not appearance. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.²

These are trial-average secondary outcomes, not promises. But they are why prescribers talk about weight management as health management. If you have a weight-related condition, your own readings, such as blood pressure or blood sugar, can be a useful part of the stay-or-stop discussion alongside the scales.

It also means the right answer can differ between people who reach a similar weight. Someone whose health markers have improved a lot may weigh the decision differently from someone whose main goal was a specific weight.

07 · What happens when you stop

What stopping involves

Stopping is simple to do, and the medicine leaves your body gradually rather than all at once. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

The medicine helps you feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ When it clears, that support fades, so planning matters. Your prescriber can talk you through what to expect and how to plan food, activity and follow-up.

Practical steps many people find sensible before stopping:

• discuss the timing with your prescriber rather than stopping suddenly after a missed order;
• agree a plan for meals, protein and activity for the months afterwards;
• keep weighing yourself on a regular schedule so changes are spotted early;
• ask what to do if your appetite or weight starts moving in a direction you do not want.

If you are stopping because of side effects, mention them. Sometimes a dose can be held longer or stepped down within the licence instead.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed, so the SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.

08 · Do not stretch doses

Why stretching or splitting doses is not the answer

Trying to stay on treatment longer by making pens last is not a safe workaround.

Altering doses outside the licence means unknown dosing accuracy and no safety data.

If cost is what is pushing you to stretch, speak to us first. We offer Klarna and pay-monthly options with no subscription lock-in.

09 · Staying on track

Staying consistent, hydrated and supplied

Staying on treatment for as long as it helps depends on consistency and on feeling well enough to continue. Mounjaro is injected once a week, on the same day each week, at any time of day, with or without food, and there is no best time of day.¹ Many people choose a weekend morning so early side effects fall on days off.

Hydration is a common worry. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ Because appetite can dip, many people find that sipping fluids regularly through the day is easier than drinking a lot at once. If you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away. You can also report any suspected side effect through the Yellow Card scheme.¹⁹

Missed doses should not derail things. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other.¹

Travel does not need to interrupt treatment either. In-use pens tolerate up to 30 days not above 30°C, so most holidays need no special arrangements, and pens should go in hand luggage because hold luggage can fall below freezing.¹ Keep unused pens in the fridge at 2–8°C.

10 · NHS and private routes

NHS and private routes: does it change how long?

The route you use affects access and cost, not the clinical logic of reviewing your response. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶

Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. With either route, your length of treatment should be decided with a prescriber who reviews your response, not by supply or budget alone.

On a private route, running costs are worth planning for. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg, also before discounts. Prices checked 11 October 2026.

11 · Other GLP-1 options

If you are weighing up a different GLP-1

Switching medicine is a separate decision from stopping, and it is one for your prescriber. Wegovy (semaglutide) is the other once-weekly injection widely used in the UK, with pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, and a licensed 2.4mg maintenance dose for weight management.¹⁸ Its titration steps up after at least four weeks, reaching 2.4mg from week 17.

Liraglutide is different again: it is a daily injection supplied at 6mg/ml, unlike once-weekly Mounjaro and Wegovy. Each medicine has its own review points. If you are thinking about a change because of tolerability or results, see our Wegovy pen page and talk it through with the prescribing team. Our related guides on how long you can stay on GLP-1 for weight loss, how long to stay on GLP-1 medication and how long you can stay on weight loss injections go into more depth on duration.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹